Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Mariola (Anonymous, 5.173.248.) Polska 16 months ago

Will the availability of Sabril improve?

Hello, watching the page I noticed that in many pharmacies appeared Sabril, does it mean that in a moment will be available throughout the Polish?

1 answer

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Aleksandra Żywiec-Pelczar Pharmacist

16 months ago

The availability of Sabril tablets has been steadily increasing since the second half of November, as shown by our statistics: https://www.gdziepolek.pl/produkty/68471/sabril-tabletki-powlekane/statystyki Currently, the drug in the form of tablets is available in 11% of pharmacies integrated with our system. According to the official announcement of Sanofi-Aventis published in August 2022, the supply restrictions of Sabril 500 mg were caused by delays in the supply of the active substance vigabatrin from the supplier. The date of restoration of normal delivery mode was forecast for the first quarter of 2023. It can therefore be expected that the availability of the drug will stabilize, but due to the fact that the liquidity of supply is influenced by many factors, often difficult to predict, there is no guarantee that this will happen. Any new information can be tracked using the following page: https://www.gdziepolek.pl/produkty/68471/sabril-tabletki-powlekane-news/apteki By checking the box "Notify about new information", you can subscribe to notifications and receive new information about the availability of the drug by e-mail.

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists